Revenue: The sum of all revenue fields included for a company's operating activities.
Recursion Pharmaceuticals, Inc. (RXRX) had Revenue of $19.22M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$19.22M |
$-171.90M |
|
$20.16M |
|
$-0.94M |
|
$195.45M |
|
$-176.23M |
|
$4.33M |
|
$-171.90M |
|
$-171.90M |
|
$-171.90M |
|
$-171.90M |
|
$-171.90M |
|
$-171.90M |
|
$-176.23M |
|
$-152.38M |
|
417.36M |
|
417.36M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$587.16M |
|
$120.04M |
|
$715.19M |
|
$1.30B |
|
$164.03M |
|
$14.20M |
|
$219.18M |
|
$383.21M |
|
$919.15M |
|
$413.56M |
|
$919.15M |
|
432.83M |
|
| Cash Flow Statement Financials | |
$-208.38M |
|
$-13.08M |
|
$138.19M |
|
$603.02M |
|
$533.85M |
|
$-69.18M |
|
$62.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.58 |
|
-- |
|
-- |
|
0.02 |
|
0.03 |
|
-4.88% |
|
-916.75% |
|
-916.75% |
|
-- |
|
-894.23% |
|
-894.23% |
|
$-213.36M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.89 |
|
101.16 |
|
-18.70% |
|
-41.57% |
|
-13.20% |
|
-18.42% |
|
$2.12 |
|
$-0.51 |
|
$-0.50 |
|